New Targeted Drug For Leukaemia Approved, 35% Of Patients' Cancer Cells Disappear Completely!
University of Michigan Hospitals-Michigan Medicine
New Study: Nmn Supplementation Activates Longevity Proteins To Reduce Stem Cell Senescence And Restore Mitochondrial Function
Airway Announces First Patient To Receive Dose In Bpd Trial
Coronary Heart Disease, How To Use The Right Medication?
Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy!
